CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of EUR 53.59 billion. The enterprise value is 123.85 billion.
Market Cap | 53.59B |
Enterprise Value | 123.85B |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
Earnings Date | Feb 12, 2025 |
Ex-Dividend Date | Oct 21, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.08% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 11.92.
PE Ratio | 11.92 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.49, with an EV/FCF ratio of 81.88.
EV / Earnings | 27.54 |
EV / Sales | 0.35 |
EV / EBITDA | 7.49 |
EV / EBIT | 13.54 |
EV / FCF | 81.88 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.10.
Current Ratio | 0.80 |
Quick Ratio | 0.54 |
Debt / Equity | 1.10 |
Debt / EBITDA | 4.80 |
Debt / FCF | 49.02 |
Interest Coverage | 3.30 |
Financial Efficiency
Return on equity (ROE) is 6.70% and return on invested capital (ROIC) is 3.81%.
Return on Equity (ROE) | 6.70% |
Return on Assets (ROA) | 2.37% |
Return on Capital (ROIC) | 3.81% |
Revenue Per Employee | 1.27M |
Profits Per Employee | 17,331 |
Employee Count | 300,000 |
Asset Turnover | 1.46 |
Inventory Turnover | 17.78 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.55% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -37.55% |
50-Day Moving Average | 52.82 |
200-Day Moving Average | 55.89 |
Relative Strength Index (RSI) | 24.17 |
Average Volume (20 Days) | 1,508 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.29 |
Income Statement
In the last 12 months, CVS Health had revenue of EUR 329.27 billion and earned 4.50 billion in profits. Earnings per share was 3.55.
Revenue | 329.27B |
Gross Profit | 45.47B |
Operating Income | 8.55B |
Pretax Income | 6.03B |
Net Income | 4.50B |
EBITDA | 12.66B |
EBIT | 8.55B |
Earnings Per Share (EPS) | 3.55 |
Balance Sheet
The company has 8.68 billion in cash and 74.15 billion in debt, giving a net cash position of -65.47 billion.
Cash & Cash Equivalents | 8.68B |
Total Debt | 74.15B |
Net Cash | -65.47B |
Net Cash Per Share | n/a |
Equity (Book Value) | 67.34B |
Book Value Per Share | 53.41 |
Working Capital | -15.50B |
Cash Flow
In the last 12 months, operating cash flow was 4.13 billion and capital expenditures -2.62 billion, giving a free cash flow of 1.51 billion.
Operating Cash Flow | 4.13B |
Capital Expenditures | -2.62B |
Free Cash Flow | 1.51B |
FCF Per Share | n/a |
Margins
Gross margin is 13.81%, with operating and profit margins of 2.60% and 1.37%.
Gross Margin | 13.81% |
Operating Margin | 2.60% |
Pretax Margin | 1.83% |
Profit Margin | 1.37% |
EBITDA Margin | 3.84% |
EBIT Margin | 2.60% |
FCF Margin | 0.46% |
Dividends & Yields
This stock pays an annual dividend of 2.46, which amounts to a dividend yield of 5.78%.
Dividend Per Share | 2.46 |
Dividend Yield | 5.78% |
Dividend Growth (YoY) | 10.47% |
Years of Dividend Growth | 2 |
Payout Ratio | 66.07% |
Buyback Yield | 2.08% |
Shareholder Yield | 7.86% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CVS Health has an Altman Z-Score of 2.13. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.13 |
Piotroski F-Score | n/a |